Biron, CA (2010). More things in heaven and earth: defining innate and adaptive immunity. Nat. Immunol., 11: 1080-1082.
Brudno, JN; Somerville, RP; Shi, V; Rose, JJ; Halverson, DC; Fowler, DH; Gea-Banacloche, JC; Pavletic, SZ; Hickstein, DD; Lu, TL; Feldman, SA; Iwamoto, AT; Hansen, BG; Blacklock-Schuver, B; Hakim, FT; Rosenberg, SA; Gress, RE and Kochenderfer, JN (2016). Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease. J. Clin. Oncol., 34: 1112-1121.
Chiang, HC; Liao, AT; Jan, TR; Wang, YS; Lei, HJ; Tsai, MH; Chen, MF; Lee, CY; Lin, YC; Chu, RM and Lin, CS (2013). Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model. Vet. Immunol. Immunopathol., 151: 207-216.
Christaki, E; Diza, E; Giamarellos-Bourboulis, EJ; Papadopoulou, N; Pistiki, A; Droggiti, DI; Georgitsi, M; Machova, A; Lambrelli, D; Malisiovas, N; Nikolaidis, P and Opal, SM (2015). NK and NKT cell depletion alters the outcome of experimental pneumococcal pneumonia: relationship with regulation of interferon-γ production. J. Immunol., Article ID 532717.
Denecke, C; Yuan, X; Ge, X; Kim, IK; Bedi, D; Boenisch, O; Weiland, A; Jurisch, A; Kotsch, K; Pratschke, J; Reutzel-Selke, A and Tullius, SG (2013). Synergistic effects of prolonged warm ischemia and donor age on the immune response following donation after cardiac death kidney transplantation. Surgery. 153: 249-261.
Duggan, MC; Campbell, AR; McMichael, EL; Opheim, KS; Levine, KM; Bhave, N; Culbertson, MC; Noel, T; Yu, Li and Carson, WE (2017). Co-stimulation of the fc receptor and interleukin-12 receptor on human natural killer cells leads to increased expression of cd25. Oncoimmunology. 16: 7(2): e1381813.
Gerner, W; Kaser, T and Saalmuller, A (2009). Porcine T lymphocytes and NK cells--an update. Dev. Comp. Immunol., 33: 310-320.
Hsiao, YW; Liao, KW; Hung, SW and Chu, RM (2004). Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity. J. Immunol., 172: 1508-1514.
Huang, YC; Hung, SW; Jan, TR; Liao, KW; Cheng, CH; Wang, YS and Chu, RM (2008). CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells. J. Leukocyte Biol., 84: 1501-1510.
Knapp, DW; Leibnitz, RR; DeNicola, DB; Turek, JJ; Teclaw, R; Shaffer, L and Chan, TC (1993). Measurement of NK activity in effector cells purified from canine peripheral lymphocytes. Vet. Immunol. Immunopathol., 35: 239-251.
Knapp, DW; Turek, JJ; DeNicola, DB; Chan, TC; Carter, WO; Snyder, PW and Robinson, JP (1995). Ultra-structure and cytochemical staining characteristics of canine natural killer cells. Anat. Rec., 243: 509-515.
Macêdo, AA; Marciano, AP; Rocha, LM; Alves-Júnior, JR; Faria, AM; Bittar, JF; Araújo, MS; Santos, RL and Martins-Filho, OA (2013). Comparative phenotypic profile of subpopulations of peripheral blood leukocytes in European (Bos taurus taurus) and Zebu cattle (Bos taurus indicus). Genet. Mol. Res., 12: 6838-6849.
Mathew, S; Kim, J and Mathew, P (2014). Characterization of human CS1 gene promoter in NK and B cells. J. Immunol., 126: 10.
Michael, HT; Ito, D; Cullar, VC; Zhang, B; Miller, JS and Modiano, JF (2013). Isolation and characterization of canine natural killer cells. Vet. Immunol. Immunop., 155: 211-217.
Nariai Nakada, Y; Nariai, K; Kosaka, T; Kuwabara, M and Kiuchi, Y (1999). Morphological observation of canine
natural killer cells mediated cytotoxicity. J. Vet. Med. Sci., 61: 835-838.
Odeberg, J; Browne, H; Metkar, S; Froelich, CJ; Branden, L; Cosman, D and Soderberg-Naucler, C (2003). The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J. Virol., 77: 4539-4545.
Orange, JS (2006). Human natural killer cell deficiencies. Curr. Opin Allergy Clin. Immunol., 6: 399-409.
Ribatti, D (2017). Historical overview on the morphological characterization of large granular lymphocytes/natural killer cells. Immunol. Lett., 190: 58-63.
Roquilly, A; Broquet, A; Jacqueline, C; Masson, DP; Segain, JP; Braudeau, C; Vourc’h, M; Caillon, JP; Altare, F; Josien, R; Retière, C; Villadangos, J and Asehnoune, K (2014). Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage. Crit. Care Med., 42: e752-e761.
Shin, DJ; Park, JY; Jang, YY; Lee, JJ; Lee, YK; Shin, MG; Jung, JY; Carson, WE 3rd; Cho, D and Kim, SK (2013). Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cells. Vet. Immunol. Immunopathol., 153: 249-259.
Stojanovic, A; Fiegler, N; Brunner-Weinzierl, M and Cerwenka, A (2014). CTLA-4 is expressed by activated mouse NK cells and inhibits NK cell IFN-γ production in response to mature dendritic cells. J. Immunol., 192: 4184-4191.
Talleur, AC; Triplett, BM; Federico, S; Mamcarz, E; Janssen, W; Wu, W; Shook, D; Leung, W and Furman, WL (2017). Consolidation therapy for newly diagnosed pediatric patients with high-risk neuroblastoma using busulfan/melphalan, autologous hematopoietic cell transplantation, anti-GD2 antibody, granulocyte-macrophage colony-stimulating factor, interleukin-2, and haploidentical natural killer cells. Biol. Blood Marrow Tr., 23: 1910-1917.
Vankayalapati, R; Klucar, P; Wizel, B; Weis, SE; Samten, B; Safi, H; Shams, H and Barnes, PF (2004). NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J. Immunol., 172: 130-137.